Skip to content
Healthcare
KZActiveBIN 180240027806
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "ЛИМФА СИ"

Director
Киноятов Данияр Абаевич
Incorporated
20.02.2018
Address
Акмолинская область мкр. 3, стр. 110
РНН
031600220910

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ЛИМФА СИ"
BIN
180240027806
Status
Active
Director
Киноятов Данияр Абаевич
Registration date
20.02.2018
Activity
Деятельность больниц широкого профиля и специализированных больниц
Legal address
Акмолинская область мкр. 3, стр. 110

In government contracts over 2 years

  • Акмолинская область, г.Степногорск, МИКРОРАЙОН 3, 110 matches the registered one

    contract of 30.09.2026
VAT payer
Yes, since 14.01.2026
КАТО
111810000
РНН
031600220910
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 51 до 100 чел.

Has changed

Procurement role
Поставщик

Activities

2
86101primary

Деятельность больниц широкого профиля и специализированных больниц

Secondary

  • 68202Аренда (субаренда) и управление собственными или арендованными бизнес-центром, офисными помещениями, административным зданием
Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
23.8M
2025
25.6M+138%
2024
10.8M-27%
2023
14.7M+7%
2022
13.7M+361%
2021
3M
·23.8M
2026year to date
+138%25.6M
2025
-27%10.8M
2024
+7%14.7M
2023
+361%13.7M
2022
·3M
2021
2026
Tax paid23,766,192 ₸
Penalty1,672,362 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid25,618,493 ₸
Penalty1,524,017 ₸
Fine157,280 ₸
VAT refund0 ₸
2024
Tax paid10,763,204 ₸
Penalty528,867 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid14,739,529 ₸
Penalty163,230 ₸
Fine79,502 ₸
VAT refund0 ₸
2022
Tax paid13,747,279 ₸
Penalty22,627 ₸
Fine30,630 ₸
VAT refund0 ₸
2021
Tax paid2,981,791 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • КД

    Киноятов Данияр Абаевич

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

Active legal entity ТОО "ЛИМФА СИ" (BIN 180240027806), Akmola Region. Registered in 2018, 8 years on the market. Primary classifier activity: healthcare. Additional activities (1). Small enterprise, headcount: 51 to 100 employees. In 2025, 25.6M ₸ was paid into the budget in taxes. Public procurement: 145 contracts as a supplier, total value 81M ₸; the latest contract was signed in 2026. Procurement of the АО «Самрук-Казына» group: 2 contracts as a supplier. Automated screening of open registries found no risk indicators for «ЛИМФА СИ». Latest registry change: change in activities, March 1, 2026. Number of founders: 1. Director on record: Киноятов Данияр Абаевич. Per the registry as of June 11, 2026.

Data sources and disclaimer

Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.